Last updated on July 2018

BGB 3111 in Combination With Obinutuzumab in Subjects With B-Cell Lymphoid Malignancies


Brief description of study

This study is evaluating the safety and preliminary efficacy of BGB-3111 in combination with obinutuzumab in subjects with B-cell lymphoid malignancies.

Clinical Study Identifier: NCT02569476

Contact Investigators or Research Sites near you

Start Over

William Novonty, MD

The Alfred Hospital
Melbourne, Australia
1.05miles

William Novonty, MD

St Frances Xavier Cabrini Hospital
Malvern, Australia
2.99miles

William Novonty, MD

St Vincent's Hospital Melbourne
East Melbourne, Australia
3.31miles

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.